Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial.
Trupti Nagendra PrasadSanjay Kumar BhadadaVeenu SinglaNeelam AggarwalSant RamUttam Chand SainiAshok KumarRimesh PalPublished in: Therapeutic advances in endocrinology and metabolism (2023)
Prospectively registered in Clinical Trial Registry of India (CTRI/2022/02/039978).